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Mechanical competence of 
ovariectomy-induced compromised 
bone after single or combined 
treatment with high-frequency 
loading and bisphosphonates
Camargos G. V.1,3, Bhattacharya P.2, van Lenthe G. H.2, Del Bel Cury A. A.3, Naert I.1, Duyck 
J.1 & Vandamme K.1
Osteoporosis leads to increased bone fragility, thus effective approaches enhancing bone strength 
are needed. Hence, this study investigated the effect of single or combined application of high-
frequency (HF) loading through whole body vibration (WBV) and alendronate (ALN) on the 
mechanical competence of ovariectomy-induced osteoporotic bone. Thirty-four female Wistar rats 
were ovariectomized (OVX) or sham-operated (shOVX) and divided into five groups: shOVX, OVX-
shWBV, OVX-WBV, ALN-shWBV and ALN-WBV. (Sham)WBV loading was applied for 10 min/day  
(130 to 150 Hz at 0.3g) for 14 days and ALN at 2 mg/kg/dose was administered 3x/week. Finite 
element analysis based on micro-CT was employed to assess bone biomechanical properties, 
relative to bone micro-structural parameters. HF loading application to OVX resulted in an enlarged 
cortex, but it was not able to improve the biomechanical properties. ALN prevented trabecular bone 
deterioration and increased bone stiffness and bone strength of OVX bone. Finally, the combination 
of ALN with HF resulted in an increased cortical thickness in OVX rats when compared to single 
treatments. Compared to HF loading, ALN treatment is preferred for improving the compromised 
mechanical competence of OVX bone. In addition, the association of ALN with HF loading results in 
an additive effect on the cortical thickness.
Osteoporosis is a skeletal disease characterized by low bone mass and micro-architectural deterioration 
of the bone tissue, leading to decreased bone strength predisposing increased risk of fractures1. This dis-
ease is associated with estrogen deficiency after menopause, which is responsible for shifting the balance 
between bone resorption and bone formation toward an increased level of bone resorption2,3. With an 
increasing aging population worldwide, osteoporosis has become a growing health concern, since the 
augmented risk of bone fractures has devastating outcomes in terms of mortality, decreased autonomy 
and healthcare costs4. Thus, therapies that increase the bone mechanical competence in medical com-
promised conditions are required.
The current therapies to prevent bone loss in estrogen-deficient state are via drugs that affect bone 
metabolism, such as biphosphonates (BPs). The biphosphonate drug alendronate is a potent anti-resorptive 
agent5, with evidenced reduction of fracture risk in postmenopausal women6. However, it has some 
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limitations and side effects that affect long-term administration and patient’s adherence7–9. Alternatively 
to the pharmacological treatment with BPs, biomechanical therapies have been proposed to treat osteo-
porosis due the profound anabolic effects of mechanical loading on bone10. In particular, the application 
of high-frequency (HF) loading via whole body vibration (WBV) has been shown to promote bone 
formation, and even recover bone loss arising from osteoporotic conditions11,12.
The anti-fracture efficacy of these osteoporosis therapies was assessed in previous studies by using dual 
energy X-ray absorptiometry (DXA) based on bone mineral density (BMD)13,14. However, DXA-BMD is 
not an appropriate predictor for the strength of the bone because of the poor association between BMD 
change and bone fragility15. As the method is based on a two-dimensional projection measurement of the 
three-dimensional bone structure, it lacks the ability to explore macro- and micro-architectural features 
of the bone16. Thus, fracture risk cannot be directly inferred from BMD, and surrogates for assessment 
of bone mechanical competence that consider bone geometric aspects are needed.
In this context, finite element (FE) analysis provides an approach to assess bone biomechanical 
properties17,18, particularly when combined with specimen-specific high-resolution data obtained from 
micro-computed tomography, from which the bone micro-architecture can be easily obtained19. Therefore, 
the aims of the present study were: (i) to investigate the effect of single or combined application of HF 
WBV and ALN on the mechanical competence of bone originating from osteoporotic animals; and (ii) 
to determine how the changes in trabecular and cortical bone micro-structure after these interventions 
contribute to the bone biomechanical properties.
Methods
Animals and experimental design. The protocol of the animal experiment was approved by the 
local ethical committee (P050/2011), complied with ARRIVE guidelines20 for preclinical studies and was 
performed according to the Belgian animal welfare regulations and guidelines.
A total of 34 female Wistar rats at 12 weeks of age were used in the present study. Twenty-seven 
animals underwent ovariectomy surgery [OVX], while the remaining seven animals were subjected 
to sham-ovariectomy surgery [shOVX]. (Sham)-ovariectomy surgery was performed at Charles River 
Laboratories (Charles River, L’ Arbresle, France). For the rats subjected to sham surgery, the bilateral 
ovaries were lifted up and returned to their original position, while for the ovariectomized rats, the ova-
ries were removed. Rats arrived 5 days post-(sham)OVX surgery, with a body weight ranging between 
220 g and 250 g. Pair-feeding regimen was initiated immediately in an attempt to control the body weight 
changes throughout the study. The average daily food consumption of the shOVX animals was deter-
mined, and the quantified amount was then provided to the other animals. Animals were weighed at 
the start and once a week during the study. The OVX group was divided into 2 groups, an untreated 
group [OVX] (n = 13) and a group treated with the anti-resorptive bisphosphonate drug alendronate 
[ALN] (n = 14). Alendronate sodium trihydrate (A4978-100MG, Sigma-Aldrich, Bornem, Belgium) was 
injected subcutaneously 3 days/week at a dose of 2 mg/kg body weight/dose, starting 5 days post-OVX 
surgery21. Saline administration (0.9% NaCl) was performed according to the same time schedule to the 
rats of the OVX and shOVX groups. Injections were administered till the day of euthanasia (i.e. 14 days 
after starting the mechanical stimulation). The animals of OVX and ALN groups were further divided 
into subgroups relative to the loading condition (sham-WBV versus WBV), resulting in 4 experimental 
groups (OVX-shWBV, n = 7; OVX-WBV, n = 6; ALN-shWBV, n = 6; ALN-WBV, n = 8). The 5th group, 
namely the shOVX group (n = 7), did not receive mechanical stimulation, and served as a negative con-
trol to illustrate normal bone characteristics over the course of the experiment. The OVX-shWBV group 
served as positive control to demonstrate the changes occuring during the development of osteoporotic 
condition following ovariectomy.
Vibration device and loading protocol. HF mechanical loading was initiated 6 weeks post-(sham)
ovariectomy. This time lapse was considered to be adequate for inducing significant bone changes 
in the rat long bones in response to ovariectomy12. The loading was applied by means of WBV via a 
custom-made vibration device. The WBV loading was administered during 14 days for 10 minutes/day 
according to a protocol that consisted of 10 consecutive frequency steps (130, 135, 140, 145, 150, 130, 
135, 140, 145 and 150 Hz), each of these applied for 1 minute at an acceleration of 0.3g21. WBV was 
applied to the animals individually, taking into account the animal’s body weight. Intervals of 24-hours 
between the loading sessions were respected.
Specimen preparation and micro-X-ray computed tomography analysis. After euthanasia of 
the animals by cervical displacement under isoflurane-induced anaesthesia, the hindlimbs were excised 
and the surrounding soft tissues removed. The tibiae were retrieved and immediately fixated in 10% 
CaCO3–buffered formalin solution (pH 7.4) at 4 °C for 48 h. The samples were further kept in the 70% 
ethanol at 4 °C until the day of μ CT scanning.
For assessment of the bone micro-architecture in the experimental groups, the proximal part of the 
tibiae was examined ex vivo using a desktop μ CT system, commercially available as Skyscan 1172 (Bruker, 
Kontich, Belgium). During scanning, the tibia was placed in the polyethylene tube and immobilized 
inside the tubes by means of soft modeling clay. The bone samples were scanned along the mid-sagittal 
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planes in the mid-diaphyseal regions to obtain the μ CT images. The scanning parameters were 6 μ m pixel 
size, 50 kV X-ray voltage, 200 μ A electric current and 0.5 mm Al filter.
Subsequently, the reconstructed 3D data sets were quantified using CTAn automated image analysis 
system (Bruker, Kontich, Belgium). For this, the volume of interest (VOI) for both trabecular and cor-
tical analyses was defined in axial direction by using the growth plate as reference. The VOI started at a 
distance of 4.2 mm distally from the growth plate and extended towards the diaphysis for 1.5 mm (250 
slices) (Fig. 1a). In each transverse slice of the VOI, the ROI was delineated manually matching with the 
area occupied by trabecular (Fig.  1b) or cortical bone (Fig.  1c) to perform trabecular or cortical bone 
analysis, respectively.
For trabecular bone analysis, the bone volume (BV), bone volume fraction (BV/TV), trabecular 
thickness (Tb.Th), trabecular separation (Tb.Sp) and trabecular number (Tb.N) were calculated 3D as 
measurements of trabecular bone mass and its distribution. The trabecular architecture was quantified 
by calculating the connectivity of the trabecular network (trabecular bone pattern formation, TBPf) and 
structure model index (SMI). For cortical bone analysis, the periosteal perimeter (Ps.Pm), medullary area 
(Ma.Ar), endocortical perimeter (Ec.Pm) and mean polar moment of inertia (MMI) were calculated in 
2D as measurements of cortical bone mass and its distribution. The porosity (Ct.Po) and cortical thick-
ness (Ct.Th) were calculated 3D as measurements of cortical bone mass and its distribution according 
to standard procedures22.
Structural analysis. Finite element models of all bone samples were created by a direct conversion 
of bone voxels to cubic hexahedral elements23. The three-dimensional (3D) models of bone presented a 
fixed length in z-direction (3.0 mm) that corresponded to the VOI evaluated in the μ CT analysis (Fig. 2). 
These models consisted of 3.8 to 6.4 million elements, having between 12.2 and 21.7 million degrees of 
freedom. Linear and isotropic material behavior was assumed. Material properties were applied, using 
typical values for bone (Young’s modulus, E = 10 GPa and Poisson’s ratio, ν = 0.3). Identical material 
properties were used for all groups, thereby enabling to isolate the effects of micro-architectural differ-
ences on bone stiffness and bone strength. Boundary conditions that represented uniaxial compression 
tests were defined in order to determine the bone mechanical competence. The nodes at the top surface 
of samples were displaced in axial direction by 1% of total height. Since all models had the same z-extent, 
1% of strain in z-direction corresponds to a standard z-displacement of 0.03 mm. All nodes at the bottom 
Figure 1. Representative μ CT images of rat tibia. (a) VOI selected for trabecular and cortical bone analysis: 
4.2 mm distally from the growth plate level and extending towards the distal diaphysis over a distance of 
1.5 mm; (b) 3D view of trabecular (b) and cortical bone (c) volume reconstructed from the selected ROI.
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of the models were restrained in the direction of the loading, except for two nodes that were restricted 
in the transversal plane too, in order to prevent rigid body rotation and translations.
For the solution of these models with up to 20 million degrees of freedom, a parallel linear finite 
element package (ParFE) with an algebraic multigrid preconditioner was used24. All the calculations 
were performed at the National Supercomputing Center (CSCS, ETH Zürich, Switzerland), where the 
code was run on up to 3072 cores of a CRAY XT5™. The latter device consists of 3688 AMD hexa-core 
Opteron processors clocked at 2.4 GHz and a high-speed interconnect with a bandwidth of 9.6 GB/s 
and a latency of 5 μ s. Numerical post-processing was done on a Sun Fire™ system; for visualization, the 
parallel open source program ParaView25 was used, running on an HP-XC cluster. Bone stiffness [N/mm] 
was determined from the FE model as the slope of the linear force–displacement relationship obtained 
up to 1% apparent compressive strain. Bone strength was determined as the minimum force required 
for 2% of the voxels (representing 2% of total bone volume) reaching at least 0.7% effective strain26,27.
Statistical analysis. Results of the bone micro-structural and biomechanical parameters were 
expressed as means ± standard deviation (SD). The differences between the means for the experimental 
groups were compared using one-way analysis of variance (ANOVA). Multiple comparisons between 
the groups were performed using Scott–Knott method and differences were considered significant at 
p < 0.05.
Results
Rats body weight. The body weight recordings at the day of arrival of the animals (i.e. 5 days post-
(sh)OVX surgery) revealed a slightly higher body weight for OVX and ALN animals compared to shOVX 
animals (246.2 ± 14.6 g for OVX, 241.1 ± 13.9 g for ALN and 230.9 ± 14.1 g for shOVX). As a conse-
quence of ovariectomy surgery, the animals from OVX and ALN group indeed have the tendency to 
gain weight compared to shOVX group, despite of the pair-feeding regime (272.5 ± 17.7 g for OVX, 
268.7 ± 18.9 g for ALN and 233.0 ± 12.8 g for shOVX). However, HF WBV application did not affect the 
rats’ body weight changes in all experimental groups.
ANOVA results. ANOVA revealed a statistically significant difference between the groups (shOVX, 
OVX-shWBV, OVX-WBV, ALN-shWBV, ALN-WBV) for bone stiffness (p = 0.000), bone strength 
(p = 0.000), trabecular micro-structural parameters (BV, p = 0.000; BV/TV, p = 0.000; Tb.Th, p = 0.014; 
Tb.SP, p = 0.000; Tb.N, p = 0.000; TBPf, p = 0.000; SMI, p = 0.000) and cortical micro-structural param-
eters (Ct.Th, p = 0.001; Ct.Po, p = 0.011; Ps.Pm, p = 0.004; Ma.Ar, p = 0.012; and MMI, p = 0.001), except 
for Ec.Pm (p = 0.056). The results of the multiple comparions between all experimental groups for each 
biomechanical and micro-structural parameter are shown in Tables 1 and 2.
Effect of WBV and/or ALN on bone micro-structure. OVX caused a marked deterioration of the 
trabecular and cortical bone micro-structure, manifested as a considerable decrease in Ct.Th (− 9%), 
BV (− 52.6%), BV/TV (− 63.6%), Tb.N (− 75.0%) and increase in Ma.Ar (+ 21.9%), Tb.Sp (+ 163.4%), 
TBPf (+ 466.7%) and SMI (+ 144.4%) (OVX-shWBV versus shOVX; Tables 1 and 2). Simultaneously, as 
Figure 2. Representative three-dimensional models of the tibial diaphysis for each group (shOVX, OVX-
shWBV, OVX-WBV, ALN-shWBV and ALN-WBV) used in μ FE analysis. 
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a compensatory mechanism after ovariectomy, a slight increase in Ps.Pm was observed in OVX-shWBV 
compared to shOVX (+ 2.8%, Table 2). Mechanical stimulation of OVX rats with HF WBV for 14 days 
had no effect on the trabecular bone, except for TBPf (+ 23.5%, OVX-WBV versus OVX-shWBV; Table 1). 
At cortical level, the mechanical treatment was able to partially reverse the bone micro-structural deteri-
oration after ovariectomy by decreasing substantially the Ma.Ar (-20.4%) and increasing Ct.Th (+ 7.2%) 
(OVX-WBV versus OVX-shWBV). Additionally, it is noteworthy that there were no differences between 
the cortical micro-structural parameters quantified for OVX-WBV and shOVX (table 2).
Unlike the single HF loading treatment, the pharmacological treatment with alendronate revealed 
a positive effect mainly on the trabecular bone micro-architecture of OVX rats, which was demon-
strated by an increase in BV (+ 107.8%), BV/TV (+ 120%) and Tb.N (+ 300%) and a decrease in Tb.Sp 
(− 58.2%), TBPf (− 64.7%) and SMI (− 50.0%). However, ALN administration was not able to improve 
the Tb.Th after ovariectomy (ALN-shWBV versus OVX-shWBV, Table 1). At cortical level, ALN adminis-
tration was associated with an increased Ct.Th (+ 9.8%) and Ct.Po (+ 60.8%) compared to OVX-shWBV 
(ALN-shWBV versus OVX-shWBV, Table  2). When compared to shOVX group, ALN also presented 
higher values of Ct.Po (+ 38.8%), Ps.Pm (+ 5%), MMI (+ 18.5%) and Ma.Ar (+ 20.3%) (ALN-shWBV 
versus shOVX, Table 2). Finally, the combined application of ALN and HF resulted in a greater increase 
in Ct.Th when compared to shOVX or ALN-shWBV groups (+ 7.1% for ALN-WBV versus shOVX and 
+ 7.4% for ALN-WBV versus ALN-shWBV; Table 2).
Effect of WBV and/or ALN on bone mechanical competence. OVX caused a substantial decrease 
in bone stiffness (− 10.7%) and bone strength (− 10.4%) compared to shOVX (OVX-shWBV versus 
shOVX; Tables 1 and 2). The mechanical treatment of OVX rats with HF loading via WBV (OVX-WBV) 
did not affect bone stiffness nor strength when compared to OVX-shWBV. However, the pharmacologic 
treatment with ALN, combined or not with WBV, significantly increased bone stiffness (+ 15.8% for 
ALN-shWBV and 14.5% for ALN-WBV) and bone strength (+ 13.8% for ALN-shWBV and + 17.6% 
for ALN-WBV) compared to the respective untreated OVX condition, with values equalling those of 
the shOVX group. In addition, no significant differences were detected between ALN-shWBV and 
ALN-WBV groups regarding bone stiffness and bone strength (Tables 1 and 2).
Mean ± Standard Deviation
Groups Stiffness (N/mm) Strength (N) BV (μ m3) BV/TV (%) Tb.Th (μ m) Tb.Sp (μ m) Tb.N (1/mm) TBPf (1/mm) SMI
shOVX 68280.0 ± 1571.6b 1042.6 ± 32.1b 1.9E+ 09 ± 2.2E+ 08b 27.5 ± 2.5b 66.1 ± 4.5 189.6 ± 8.0b 4.0 ± 0b 3.0 ± 3.0b 0.9 ± 0.3b
OVX-shWBV 60974.0 ± 3311.8a 934.2 ± 59.0a 9.0E+ 08 ± 3.1E+ 08a 10.0 ± 4.7a 64.6 ± 2.7 499.4 ± 231.3a 1.0 ± 1.0a 17.0 ± 4.0a 2.2 ± 0.3a
OVX-WBV 58399.9 ± 3989.2a 900.1 ± 63.5a 5.3E+ 08 ± 2.2E+ 08a 7.8 ± 3.1a 65.0 ± 5.4 636.6 ± 250.4a 1.0 ± 1.0a 21.0 ± 4.0a+b 2.6 ± 0.3a
ALN-shWBV 70596.1 ± 5729.3b 1063.2 ± 79.8b 1.9E+ 09 ± 4.5E+ 08b 22.0 ± 3.7a+b 57.7 ± 2.3a+b 208.7 ± 22.6b 4.0 ± 1.0b 6.0 ± 5.0b 1.1 ± 0.5b
ALN-WBV 69834.2 ± 4804.4b 1098.8 ± 69.8b 1.8E+ 09 ± 4.3E+ 08b 23.5 ± 3.3a+b 60.8 ± 6.3a+b 210.1 ± 13.9b 4.0 ± 0b 4.0  ± 1.0b 1.0 ± 0.2b
Table 1.  Results for bone stiffness, bone strength and trabecular bone micro-structural parameters (BV, BV/
TV, Tb.Th, Tb.Sp, Tb.N, TBPf, SMI) for each group evaluated. Means ± SD followed by “a” and “b” represent 
statistically significant difference from the ShOVX and OVX-shWBV group, respectively (p < 0.05).
Mean ± Standard Deviation
Groups Stiffness (N/mm) Strength (N) Ct.Po (%) Ps.Pm (μ m) Ma.Ar (μ m2) MMI (μ m4) Ec.Pm (μ m) Ct.Th (μ m)
shOVX 68280.0 ± 1571.6b 1042.6 ± 32.1b 1.4 ± 0.6 13557.6 ± 399.3b 4.8E+ 06 ± 3.7E+ 05b 1.2E+ 13 ± 1.4E+ 12 12275.2 ± 704.8 451.6 ± 20.0b
OVX-shWBV 60974.0 ± 3311.8a 934.2 ± 59.0a 1.2 ± 0.4 13944.3 ± 493.8a 5.9E+ 06 ± 4.6E+ 05a 1.3E+ 13 ± 1.5E+ 12 13727.2 ± 1595.5 410.8 ± 25.2a
OVX-WBV 58399.9 ± 3989.2a 900.1 ± 63.5a 1.0 ± 0.2 13265.2 ± 350.6b 4.7E+ 06 ± 3.3E+ 05b 1.2E+ 13 ± 1.1E+ 12 12027.7 ± 462.4 440.7 ± 23.3b
ALN-shWBV 70596.1 ± 5729.3b 1063.2 ± 79.8b 1.9 ± 0.7a+b 14231.8 ± 428.9a 5.8E+ 06 ± 6.3E+ 05a 1.5E+ 13 ± 1.9E+ 12a+b 13604.8 ± 940.8 450.4 ± 16.7 b+c
ALN-WBV 69834.2 ± 4804.4b 1098.8 ± 69.8b 1.9 ± 0.5a+b 14296.5 ± 726.0a 5.5E+ 06 ± 1.2E+ 06a 1.6E+ 13 ± 2.4E+ 12a+b 13498.0 ± 1846.6 483.6 ± 41.2 a+b
Table 2.  Results for bone stiffness, bone strength and cortical bone micro-structural parameters  
(Ct.Po, Ps.Pm, Ma.Ar, MMI, Ec.PM, Ct.Th) for each group evaluated. Means ± SD followed by: “a” represents 
statistically significant difference from ShOVX; “b” represents statistically significant difference from the 
OVX-shWBV group; and “c” represents statistically significant difference between ALN-shWBV and ALN-
WBV (p < 0.05).
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Discussion
The higher resolution of micro-computed tomography images and mechanical testing procedures28,29 
has highlighted the significance of several bone properties other than BMD for bone strength30, which 
can improve the fracture risk prediction and the assessment of anti-fracture efficacy of osteoporosis 
therapies. Impaired bone strength associated with altered bone turnover might result from decreases in 
the amount of bone mass, changes in bone micro-architecture or geometry, in the biophysical properties 
of bone tissue, or even from a combination of all of the above30. Therefore, the present study by using 
three-dimensional analysis, μ CT and μ FE analyses, evaluated the potential relation of bone mechanical 
competence with bone micro-structural changes of ovariectomy-induced compromised bone after single 
or combined treatment with HF loading and bisphosphonates.
In OVX osteoporotic rats, a decreased bone mechanical competence associated with a cortex thin-
ning and trabecular bone loss was observed. This increased bone fragility is a result of the negative bone 
multicelullar unit balance induced by estrogen withdrawal after ovariectomy, which is the morphological 
basis of bone loss and structural deterioration31. With a larger surface-to volume ratio, trabecular bone 
is rapidly affected by increases in bone resorption32. Individual trabeculae become progressively thinner, 
shifting from a plate-like shape to a rod-like shape while trabecular separation increases. Progressive 
perforation of individual rods leads to the loss of trabecular connectivity and reduces the number of 
trabeculae, resulting in trabecular micro-architecture deterioration33. These changes in trabecular 
micro-architecture were also observed in previous studies with ovariectomized rats and rapidly compro-
mise bone strength34,35. At cortical level, a higher endocortical resorption was noticed in OVX animals 
represented by an increase in Ma.Ar compared to shOVX, leading to a reduction in bone mass and cor-
tical thickness despite of the slight periosteal expansion after ovariectomy. Clinical studies in postmeno-
pausal women also reported about 50% of cortical bone loss as a result of remodelling within the inner 
(endosteal) surface adjacent to the marrow by cavitation36. Weakening of the cortical bone compartment 
is also of major importance for fragility fractures once cortical bone represents a substantial amount of 
the total bone mass, especially in the appendicular skeleton36. These results therefore demonstrate that 
micro-architectural changes after ovariectomy in either cortical or trabecular bone are responsible for 
significant variations in the bone mechanical properties.
The mechanical treatment with HF loading was not able to oppose the negative effects of ovariec-
tomy on the bone mechanical competence. HF loading increased the cortical thickness of OVX rats by 
decreasing the endocortical resorption, represented in this study by lower values of Ma.Ar compared to 
OVX-shWBV. Notwithstanding this, the increase in cortical thickness after HF loading was not able to 
improve the OVX bone strength and bone stiffness since this mechanical stimuli did not prevent the tra-
becular bone deterioration, as also demonstred by Hatori et al.37. In agreement with our results, a recent 
study with ovariectomized rats also did not find substantial effects of mechanical stimulation neither on 
bone biomechanical properties nor on trabecular bone micro-architecture (4 weeks of WBV loading)38. 
However, after 12 weeks of mechanical treatment an improvement of the trabecular bone parameters of 
OVX animals could be noticed38. These results are in contrast to those reported by Tezval et al.35 and 
Sehmisch et al.34, who found that treatment with WBV for 5 weeks resulted in improved bone strength 
and bone mass, equalling the levels as observed in untreated sham rats. It is worth noting that differ-
ences could arise due to the skeletal site evaluated in the latter studies. The present study as well as the 
study by Chen and co-workers38 investigated the effects of mechanical treatment at the tibia, while the 
study of Tezval et al.35 and Sehmisch et al.34 evaluated the femur and vertebral body, respectively. The 
tibia was chosen because this sites enables concomittantly trabecular and cortical bone analysis, which 
is not the case for the vertebral body. Furthermore, the femura were used for isolation of bone-marrow 
derived stromal cells and investigation of the role of hormonal and mechanical influences on the pro-
genitor cells’ biology. Also, the response of the skeletal tissues to mechanical loading depends on several 
factors including magnitude, duration and rate of stimulus39. Hence, it might be that the short duration 
of experimental period used in the present study, namely 14 days, has been insufficient to increase the 
bone mechanical competence in ovariectomized rats, since more densely mineralized bone is removed 
after ovariectomy and replaced by younger less mineralized bone, which has reduced stiffness40.
Unlike single HF loading treatment, alendronate administration was able to significantly enhance the 
bone mechanical competence in ovariectomized rats. This might be attributed to the efficacy of this drug 
in preventing ovariectomy-induced trabecular bone micro-architectural deteterioration. The large sur-
face area of trabecular bone is an advantage in therapeutics because it facilitates the access of biphospho-
nates to inhibit matrix remodeling32. At the same time, a limited effect of ALN on the endocortical bone 
remodeling was observed, since the drug was not able to decrease the Ma.Ar enlargement that occurs 
after ovariectomy. As biphosphonates act by binding avidly to mineralized bone matrix41, and consider-
ing that at intracortical or endocortical surfaces there is less volume of mineralized cortical bone matrix, 
the accessibility of this drug to the bone remodeling that is occuring at these surfaces is reduced42,43. 
Consequently, osteoclasts initiating remodeling upon a Haversian canal surface might not encounter and 
engulf matrix containing drug and continue reabsorbing bone at endocortical surface32, particularly in 
rodents that lack a true Haversian canal system44. Nevertheless, the association of ALN with HF loading 
seems to provide an additive effect at the level of endorcortical surface, demonstrated by lower values 
of Ma.Ar in comparison to the single pharmacological treatment. Thus, the effect of HF stimuli on the 
endocortical surface combined with the effect of ALN at the periosteal surface level contributed for an 
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enlarged cortical thickness when compared to single application of these treatments. Chen et al.38 also 
showed that WBV enhanced the effect of alendronate on the trabecular micro-architecture in ovariecto-
mized rats over 12 weeks, but the micro-structural changes at cortical level after this combined treatment 
was not investigated. In the present study, although there is a trend of the combined treatment with 
HF loading and ALN in improving trabecular micro-architecture and bone strength after ovariectomy, 
the results were statistically not significant when compared to single pharmacological treatment over 2 
weeks. Therefore, long-term studies are needed in order to elicit the role of HF loading, combined or 
not with ALN, on trabecular bone.
From a biomechanical point of view, an effective treatment for bone fragility should improve the 
extrinsic biomechanical properties of bone but at the same time not substantially impair the intrinsic 
properties. However, it is rare for a treatment to achieve this combination of effects45. Bisphosphonates, 
by reducing excessively bone turnover, decreases the renewal of bone tissue and consequently increases 
the accumulation of older and extensively mineralized bone46. As a consequence, the bone becomes 
more brittle and therefore unable to absorb energy by elastic deformation. Additionally, it leads to the 
accumulation of damaged bone, facilitating micro-crack proliferation47. Therefore, recent studies have 
provided a well documented association between atypical fractures and long-term oral intake of alendro-
nate8,48, which is a growing clinical concern9. Hence, in order to achieve a safer and better clinical effect 
on osteoporosis treatment, the combined use of ALN with HF WBV could be advised. Exercise–induced 
improvements in the inorganic bone component does not seem to restrict the mineralization degree, 
improves also the water content49, which is assumed to confer additional biomechanical advantages50 as 
the tissue become less brittle and more able to accomodate the loads applied to the bone before devel-
oping micro-damage. This combination therapy might decrease the dosage of ALN in clinical patients. 
Using a reduced dosage of biphosphonates (lower weekly dose or dosing every 2 weeks) is an unproven 
but appealing alternative9, providing an adequate but less complete surpress of bone turnover51 and is 
likely to provide fracture risk reduction.
The cross-sectional design and the relatively short-term experiment period of this study were the main 
limitations. Therefore, it remains unclear whether longer-term changes on the bone micro-architecture 
after HF and ALN interventions would still affect the bone mechanical competence. Furthermore, an 
in silico technique was used in this study to determine the bone stiffness and bone strength based on 
bone micro-architecture since this methodology was successfuly validated in previous studies showing 
high precision17,18. Future studies should also consider the inclusion of other methodologies to evaluate 
the biophysical properties of bone tissue, such as the degree and type of collagen cross-linking, hydra-
tion, the mineral crystal size and their crystallinity in order to provide a complete insight into the bone 
mechanical competence.
In conclusion, in comparison to single treatment with HF loading, ALN proved to be better in improv-
ing the mechanical competence of OVX-induced compromised bone. In addition, the association of ALN 
with HF loading resulted in an additive anabolic effect on the cortical thickness.
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